These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 7853690

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics].
    Kaino Y, Kida K, Matsuda H.
    Jpn J Antibiot; 1994 Nov; 47(11):1565-75. PubMed ID: 7853687
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
    Fujii R, Abe T, Tajima T, Terashima I, Meguro H, Nakazawa S, Sato H, Niinou K, Sunakawa K, Yokota T.
    Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
    [Abstract] [Full Text] [Related]

  • 4. [Optimum dose study of cefozopran in the pediatric field].
    Fujii R, Sunakawa K, Sato Y, Yokota T, Yoshimura K, Kondoh Y, Kawaoi Y, Terashima I, Meguro H, Niinou K, Toyonaga Y, Ishihara T, Iwai N, Nakamura H, Kuno K, Miyajima Y, Sakurai M, Itoh M, Kawasaki H, Suga S, Kamiya H, Fujiwara T, Inui T, Taniguchi K, Nakayama M.
    Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C.
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [Abstract] [Full Text] [Related]

  • 7. [Basic and clinical studies on cefditoren pivoxil in pediatric field].
    Motohiro T, Handa S, Yamada S, Oki S, Yoshinaga Y, Sasaki H, Aramaki M, Oda K, Sakata Y, Kato H.
    Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769
    [Abstract] [Full Text] [Related]

  • 8. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field. Pediatric Study Group of Cefpirome].
    Fujii R, Abe T, Meguro H, Tajima T, Nakazawa S, Sato H, Hirama Y, Narita A, Matsumoto K, Nakazawa S.
    Jpn J Antibiot; 1991 Jan; 44(1):84-109. PubMed ID: 2041150
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in children].
    Tajima T, Kondo Y, Negishi S, Kawashima S, Hagiwara N, Iizuka T, Kubota K, Abe T.
    Jpn J Antibiot; 1994 Nov; 47(11):1457-63. PubMed ID: 7853676
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
    Iwai N, Nakamura H, Miyazu M, Watanabe Y, Taneda Y.
    Jpn J Antibiot; 1994 Nov; 47(11):1521-35. PubMed ID: 7853682
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetic and clinical studies on cefozopran in pediatrics].
    Akita H, Sato Y, Iwata S, Yokota T, Sunakawa K.
    Jpn J Antibiot; 1994 Nov; 47(11):1485-94. PubMed ID: 7853679
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetic and clinical evaluation of cefozopran in premature and newborn patients].
    Motohiro T, Sakata Y, Nagai K, Morita J, Takagishi T, Matsuo Y, Hashimoto T, Yoshinaga Y, Hayashi M, Toyota A, Fujimoto T, Wada M, Kamizono S.
    Jpn J Antibiot; 1997 Dec; 50(12):953-66. PubMed ID: 9545672
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H.
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Takanashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Kosakai N, Yamaguchi K, Matsumoto T, Kashitani F, Tanaka M.
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.